PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.

Saved in:
Bibliographic Details
Title: PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.
Authors: Rebecca VW; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Nicastri MC; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania., Fennelly C; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Chude CI; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Barber-Rotenberg JS; Department of Biochemistry and Biophysics, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania., Ronghe A; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania., McAfee Q; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., McLaughlin NP; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania., Zhang G; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania., Goldman AR; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania., Ojha R; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Piao S; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Noguera-Ortega E; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Martorella A; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania., Alicea GM; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania., Lee JJ; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Schuchter LM; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Xu X; Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania., Herlyn M; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania., Marmorstein R; Department of Biochemistry and Biophysics, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania., Gimotty PA; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania., Speicher DW; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania., Winkler JD; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania. Winkler@sas.upenn.edu Ravi.amaravadi@uphs.upenn.edu., Amaravadi RK; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Winkler@sas.upenn.edu Ravi.amaravadi@uphs.upenn.edu.
Source: Cancer discovery [Cancer Discov] 2019 Feb; Vol. 9 (2), pp. 220-229. Date of Electronic Publication: 2018 Nov 15.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-18-0706